An MRI-based clinical decision tool to identify patients benefiting from PSMA PET/MRI in intermediate/high-risk prostate cancer
Authors
- Haifeng Wang (ORCID: https://orcid.org/0000-0003-4229-3668)
- Zuo‐Lin Xiang (ORCID: https://orcid.org/0000-0002-5725-842X)
- Shuguang Chu (ORCID: https://orcid.org/0000-0001-7703-2789)
- Zhao-Ming Gou
- Fang-Fang Huang
- Jun Zhao
Institutions
- Tongji University (CN)
- First Hospital of Jilin University (CN)
- Shanghai East Hospital (CN)
Publication Details
- Journal
- Cancer Imaging
- Published
- 2026-11-06
- DOI
- https://doi.org/10.1186/s40644-026-01157-y
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00